脑叶与深部脑出血对降压治疗的不同反应
该研究为 ATACH-2 随机临床试验的探索性事后分析,纳入 875 例(87.5%)有完整神经影像数据的急性自发性脑出血患者,其中深部出血 778 例(89%)、脑叶出血 97 例(11%),比较强化降压(收缩压 110–139 mm Hg)与标准降压(收缩压 140–179 mm Hg)的效果。多因素 logistic 回归显示,强化降压在深部脑出血中降低血肿扩大风险(OR 0.60,95%CI 0.38–0.93;p=0.024),但增加肾不良事件风险(OR 2.42,95%CI 1.29–4.72;p=0.007);在脑叶出血中血肿扩大无显著关联(OR 0.91,95%CI 0.34–2.41;p=0.9)。强化降压与 90 天不良功能结局在深部(OR 1.03,95%CI 0.71–1.51;p=0.9)和脑叶(OR 0.97,95%CI 0.31–2.95;p=0.9)脑出血中均无显著关联。作者认为结果强调需更好理解脑出血的生物学差异,可能具有治疗意义。
要点
- 深部脑出血强化降压(收缩压 110–139 mm Hg)与血肿扩大风险降低相关:OR 0.60(95%CI 0.38–0.93;p=0.024)。
- 深部脑出血强化降压与肾不良事件风险升高相关:OR 2.42(95%CI 1.29–4.72;p=0.007)。
- 脑叶脑出血强化降压与血肿扩大无显著关联:OR 0.91(95%CI 0.34–2.41;p=0.9)。
- 强化降压与 90 天不良功能结局(mRS 4–6)在深部(OR 1.03,95%CI 0.71–1.51;p=0.9)和脑叶(OR 0.97,95%CI 0.31–2.95;p=0.9)脑出血中均无显著关联。
- 该分析为 ATACH-2 的探索性事后分析,875 例中深部出血 778 例(89%)、脑叶出血 97 例(11%)。
适用人群与场景
- ATACH-2 随机临床试验中具有完整神经影像数据的急性自发性脑出血患者 875 例(占 1000 例的 87.5%),其中深部脑出血 778 例(89%)、脑叶脑出血 97 例(11%),平均年龄 62 岁,男性 62%。
- 场景为急性自发性脑出血后 4.5 小时内启动降压治疗。
诊断标准与关键阈值
- 血肿扩大定义为基线至 24 小时血肿体积增加 > 6 mL。
- 90 天功能结局按改良 Rankin 量表(mRS)评分 0–3 分 vs 4–6 分二分。
- 强化降压目标为收缩压 110–139 mm Hg,标准降压目标为收缩压 140–179 mm Hg。
处置流程与药物剂量
- 急性自发性脑出血后 4.5 小时内随机接受强化降压(收缩压目标 110–139 mm Hg)或标准降压(收缩压目标 140–179 mm Hg)。
研究设计与关键结果
- 研究类型:ATACH-2 随机临床试验的探索性事后分析;样本量 875 例(深部 778 例、脑叶 97 例);人群为急性自发性脑出血患者;干预为强化降压(收缩压 110–139 mm Hg)vs 标准降压(收缩压 140–179 mm Hg)。
- 深部脑出血:强化降压降低血肿扩大风险(OR 0.60,95%CI 0.38–0.93;p=0.024),增加肾不良事件风险(OR 2.42,95%CI 1.29–4.72;p=0.007)。
- 脑叶脑出血:强化降压与血肿扩大无显著关联(OR 0.91,95%CI 0.34–2.41;p=0.9)。
- 90 天不良功能结局:深部脑出血 OR 1.03(95%CI 0.71–1.51;p=0.9),脑叶脑出血 OR 0.97(95%CI 0.31–2.95;p=0.9),均无显著关联。
证据类型、等级与局限
- 证据类型:随机临床试验(ATACH-2)的探索性事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,结果强调需要更好地理解脑出血的生物学差异,这可能具有治疗意义。
指南或共识出处
- ATACH-2(Antihypertensive Treatment of Acute Cerebral Hemorrhage II)随机临床试验
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intensive blood pressure (BP) reduction may benefit patients with acute intracerebral hemorrhage (ICH), but it is unknown if those benefits apply equally to patients with lobar and deep ICH. Our objective was to assess the impact of intensive BP reduction on hematoma expansion (HE), 90-day functional outcomes, and renal adverse events (RAEs) in patients with deep ICH compared with those with lobar ICH.
METHODS: This was an exploratory, post hoc analysis of the Antihypertensive Treatment of Acute Cerebral Hemorrhage II (ATACH-2) randomized clinical trial, which investigated the efficacy of intensive BP reduction (110-139 mm Hg systolic BP) versus standard (140-179 mm Hg systolic BP) reduction 4.5 h after acute spontaneous ICH. Our end points of interest were HE (> 6 mL increase in hematoma volume between baseline and 24 h), 90-day functional outcome (modified Rankin Scale score 0-3 vs. 4-6), and RAEs.
RESULTS: Of 1000 ATACH-2 participants, only 875 participants (87.5%) with complete neuroimaging data were included (778 [89%] deep and 97 [11%] lobar, mean age of 62 years, 62% male). Multivariable logistic regressions results showed that intensive BP reduction decreased the risk of HE (odds ratio [OR] 0.60, 95% confidence interval [CI] 0.38-0.93; p = 0.024) and increased the risk of RAE (OR 2.42, 95% CI 1.29-4.72; p = 0.007) in deep ICH, whereas in lobar ICH results were nonsignificant for HE (OR 0.91, 95% CI 0.34-2.41; p = 0.9). Intensive BP reduction was not significantly associated with 90-day unfavorable functional outcome in either deep (OR 1.03, 95% CI 0.71-1.51; p = 0.9) or lobar (OR 0.97, 95% CI 0.31-2.95; p = 0.9) ICH.
CONCLUSIONS: In this exploratory analysis of the ATACH-2 study, intensive BP reduction was associated with reduced risk of HE and increased risk of RAE in deep but not lobar ICH. These results emphasize the need for a better understanding of the biological differences in ICH, which may have therapeutic implications.
参考来源
- Clocchiatti-Tuozzo S, Rivier CA, Qureshi AI, et al. Different Responses to Blood Pressure Reduction in Lobar and Deep Intracerebral Hemorrhage. Neurocrit Care. 2025. PMID: 40293696. doi:10.1007/s12028-025-02269-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。